Exact Mass: 502.4386

Exact Mass Matches: 502.4386

Found 13 metabolites which its exact mass value is equals to given mass value 502.4386, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Plerixafor

1,1-(1,4-Phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride dihydrate

C28H54N8 (502.4471)


Plerixafor is a hematopoietic stem cell mobilizer. It is used to stimulate the release of stem cells from the bone marrow into the blood in patients with non-Hodgkin lymphoma and multiple myeloma. These stem cells are then collected and used in autologous stem cell transplantation to replace blood-forming cells that were destroyed by chemotherapy. Plerixafor has orphan drug status in the United States and European Union; it was approved by the U.S. Food and Drug Administration on December 15, 2008. L - Antineoplastic and immunomodulating agents > L03 - Immunostimulants > L03A - Immunostimulants D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-(4-hydroxyphenyl)ethyl pentacosanoate

2-(4-hydroxyphenyl)ethyl pentacosanoate

C33H58O3 (502.4386)


   

4-(24-hydroxy-1-oxo-5-n-propyltetracosanyl)phenol

4-(24-hydroxy-1-oxo-5-n-propyltetracosanyl)phenol

C33H58O3 (502.4386)


   

ACMC-20n0cq

ACMC-20n0cq

C33H58O3 (502.4386)


   

(1R,6R,9S)-6-hydroxycaryophyllenyl (S)-6-hydroxystearate

(1R,6R,9S)-6-hydroxycaryophyllenyl (S)-6-hydroxystearate

C33H58O3 (502.4386)


   

Plerixafor

1,4-bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene, octahydrochloride

C28H54N8 (502.4471)


L - Antineoplastic and immunomodulating agents > L03 - Immunostimulants > L03A - Immunostimulants D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Hydroxytritriacontatetraenoic acid

Hydroxytritriacontatetraenoic acid

C33H58O3 (502.4386)


   

3-(4-hydroxyphenyl)propyl tetracosanoate

3-(4-hydroxyphenyl)propyl tetracosanoate

C33H58O3 (502.4386)


   

(1s,4r,5e,9r)-6,10,10-trimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-4-yl (6s)-6-hydroxyoctadecanoate

(1s,4r,5e,9r)-6,10,10-trimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-4-yl (6s)-6-hydroxyoctadecanoate

C33H58O3 (502.4386)


   

[(1s,8as)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 6-oxooctadecanoate

[(1s,8as)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 6-oxooctadecanoate

C33H58O3 (502.4386)


   

6,10,10-trimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-4-yl 6-hydroxyoctadecanoate

6,10,10-trimethyl-2-methylidenebicyclo[7.2.0]undec-5-en-4-yl 6-hydroxyoctadecanoate

C33H58O3 (502.4386)


   

(2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)methyl 6-oxooctadecanoate

(2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)methyl 6-oxooctadecanoate

C33H58O3 (502.4386)


   

(2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)methyl octadecanoate

(2,5,5,8a-tetramethyl-4-oxo-4a,6,7,8-tetrahydro-1h-naphthalen-1-yl)methyl octadecanoate

C33H58O3 (502.4386)